Protein aggregation and its impact on product quality

- Proteins aggregate in a variety of ways, most of which are unwanted in drug products.
- Possible impacts on product quality include deliverability and immunogenicity.
- Controlling aggregation is difficult and is currently primarily phenomenological.
- Improved predictive approaches to control aggregation are needed.